CEO of Odonate Therapeutics Inc (ODT, Financial) Kevin C Tang bought 769,231 shares of ODT on 06/26/2019 at an average price of $26 a share. The total cost of this purchase was $20 million.
Odonate Therapeutics Inc is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer. It is developing tesetaxel an chemotherapy agent used in the treatment of cancer. Odonate Therapeutics Inc has a market cap of $981.960 million; its shares were traded at around $36.69 .
CEO Recent Trades:
- CEO, 10% Owner Kevin C Tang bought 769,231 shares of ODT stock on 06/26/2019 at the average price of $26. The price of the stock has increased by 41.12% since.
- CEO, 10% Owner Kevin C Tang bought 50,000 shares of ODT stock on 06/18/2019 at the average price of $26.15. The price of the stock has increased by 40.31% since.
- CEO, 10% Owner Kevin C Tang bought 76,308 shares of ODT stock on 06/07/2019 at the average price of $27.36. The price of the stock has increased by 34.1% since.
- CEO, 10% Owner Kevin C Tang bought 93,692 shares of ODT stock on 06/05/2019 at the average price of $24.92. The price of the stock has increased by 47.23% since.
Directors and Officers Recent Trades:
- 10% Owner Capital, Llc Boxer bought 384,615 shares of ODT stock on 06/26/2019 at the average price of $26. The price of the stock has increased by 41.12% since.
- Director Jeff L Vacirca bought 19,231 shares of ODT stock on 06/26/2019 at the average price of $26. The price of the stock has increased by 41.12% since.
For the complete insider trading history of ODT, click here
.
